ALL vs ERNA · P/E 4.9, $56.89B cap vs P/E 0.0, rev $582.0K
The Allstate Corporation (ALL) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
ALL does not have a complete income-statement cache yet.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the ALL and ERNA stock pages for the full models.
Not investment advice.